Metabolic & Cardiometabolic
metabolic/bariatric surgery causes type 2 diabetes remission
In plain terms: Does metabolic surgery cause type 2 diabetes remission?
Part of: 🩺 bariatric / metabolic surgery
Yes—RCTs and cohorts show surgery causes far higher T2D remission than medical therapy, but remission wanes over time and relapse is common.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (10)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Ikramuddin 2018 · JAMA | RCT | mixed | high | Diabetes Surgery Study 5yr: RYGB improved composite targets but durability waned—triple-endpoint benefit not sustained at 5yr. |
| Afzal 2025 · Cureus | meta-analysis | supports | moderate | Systematic review of 10 RCTs found bariatric surgery consistently outperforms medical therapy for durable diabetes remission and glycemic control. |
| Kirwan 2022 · Diabetes Care | RCT | supports | high | ARMMS-T2D consortium design/early data: metabolic surgery durably superior to medical/lifestyle for remission. |
| Schauer 2017 · N Engl J Med | RCT | supports | high | STAMPEDE 5yr RCT: HbA1c<=6.0% in 29% (bypass)/23% (sleeve) vs 5% medical; durable glycemic superiority. |
| Mingrone 2021 · Lancet | RCT | supports | high | 10yr RCT: 37.5% surgical patients maintained diabetes remission vs 5.5% medical; relapse occurred but durable advantage held. |
| Courcoulas 2024 · JAMA | RCT | supports | high | Pooled 4-RCT ARMMS-T2D: at 7yr diabetes remission 18.1% surgery vs 6.2% medical; effect attenuates over time. |
| Celik Esmer 2026 · Obes Surg | meta-analysis | supports | high | Network meta-analysis of 11 RCTs found all bariatric procedures significantly increased T2D remission versus medical/lifestyle therapy. |
| Ikramuddin 2016 · Diabetes Care | RCT | supports | moderate | Adding Roux-en-Y gastric bypass to lifestyle-medical management achieved treatment goals more often at 3 years in uncontrolled T2D. |
| Sjostrom 2014 · JAMA | observational | supports | high | SOS: 2yr remission 72% vs 16% controls, falling to 30.4% vs 6.5% at 15yr—remission real but relapses. |
| Sjoholm 2016 · Diabetes Care | observational | supports | moderate | SOS: gastric bypass improved glucose/insulin/HOMA-IR partly independent of weight change at 2 and 10yr. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.